Table 1
| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1613-mCRC, Adv/Met, TP vs CETIRI | 1 | Y | 0 Screening | 130 | 186 | 38 | 26 | 7 | 3 | 1 | 11/27/2017 | 307 | 121 |
| 186 | 38 | 26 | 7 | 3 | 1 | |||||||||
| 2 | Y | 1 Trastuzumab + Pertuzumab | 130 | 15 | 4 | 2 | 0 | 0 | 0 | 11/27/2017 | ||||
| 2 Cetuximab + Irinotecan | 18 | 6 | 3 | 0 | 0 | 0 | ||||||||
| 33 | 10 | 5 | 0 | 0 | 0 | |||||||||
| 3 | Y | 3 Crossover: Trastuz + Pertuz | 130 | 12 | 4 | 3 | 1 | 1 | 0 | 11/27/2017 | ||||
| 12 | 4 | 3 | 1 | 1 | 0 | |||||||||
| S1815-Biliary, Met/LocAdv, GC+CPT±Nab-paclitaxel | 1 | Y | 1 Gem+Cisplatin+Nab-paclitaxel | 441 | 182 | 151 | 50 | 6 | 6 | 1 | 02/07/2019 | 279 | 117 | |
| 2 Gemcitabine + Cisplatin | 94 | 77 | 23 | 1 | 1 | 1 | ||||||||
| 276 | 228 | 73 | 7 | 7 | 2 | |||||||||
| S1922-Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect | 1 | Y | 2 FOLFIRI | 94 | 1 | 1 | 1 | 1 | 0 | 0 | 06/01/2020 | 126 | 47 | |
| 1 | 1 | 1 | 1 | 0 | 0 | |||||||||
| Yes | A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC | 1 | E | Total Registrations | 28 | 12 | 6 | 2 | 1 | 0 | 03/23/2018 | 363 | 171 | |
| 28 | 12 | 6 | 2 | 1 | 0 | |||||||||
| No | A021602-PANC, Adv PNET Blinded Cabozantinib v Placebo | 1 | E | Total Registrations | 8 | 7 | 2 | 2 | 1 | 0 | 06/11/2019 | 227 | 93 | |
| 8 | 7 | 2 | 2 | 1 | 0 | |||||||||
| A021703-COLON, Adv/Met, Chemo + Std v High dose V-D3 | 1 | E | Total Registrations | 4 | 4 | 4 | 2 | 1 | 1 | 03/04/2020 | 43 | 24 | ||
| 4 | 4 | 4 | 2 | 1 | 1 | |||||||||
| EA2142-GI NEC, Adv G3, EP vs TMZ + CAP | 1 | E | Total Registrations | 5 | 1 | 0 | 0 | 0 | 0 | 07/14/2016 | 191 | 83 | ||
| 5 | 1 | 0 | 0 | 0 | 0 | |||||||||
| EA2165-Anal, Stg II-III, Nivolumab after CMT | 1 | E | Total Registrations | 23 | 14 | 10 | 3 | 1 | 0 | 10/09/2018 | 285 | 136 | ||
| 23 | 14 | 10 | 3 | 1 | 0 | |||||||||
| 2 | E | Total Registrations | 18 | 11 | 8 | 3 | 1 | 0 | 10/09/2018 | |||||
| 18 | 11 | 8 | 3 | 1 | 0 | |||||||||
| NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy | 1 | E | Total Registrations | 14 | 5 | 3 | 1 | 0 | 0 | 04/18/2018 | 302 | 130 | ||
| 14 | 5 | 3 | 1 | 0 | 0 | |||||||||
| NRGGI005-COLON,Stg IIA, ctDNA in Adjuvant Chemotherapy | 1 | E | Total Registrations | 1 | 1 | 1 | 1 | 1 | 0 | 07/06/2020 | 2 | 2 | ||
| 1 | 1 | 1 | 1 | 1 | 0 | |||||||||